India's Biocon Biologics in fundraising talks with Baring PE Asia

Vaccine products

Biocon Biologics Limited, a unit of India’s largest biopharmaceutical company Biocon, is in talks with Asia-focused Baring Private Equity (PE) Asia to raise funding in lieu of a minority stake, multiple sources familiar with the matter told DealStreetAsia.

While the exact deal size could not be ascertained, it could be around $100 million or even more, they added.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter